{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:35:47Z","timestamp":1792690547014,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","award":["80077"],"award-info":[{"award-number":["80077"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jneuroim.2019.577136","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T17:57:30Z","timestamp":1576519050000},"page":"577136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis"],"prefix":"10.1016","volume":"339","author":[{"given":"Konstantinos","family":"Lazaridis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Baltatzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tektonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates J.","family":"Tzartos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2019.577136_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1684\/ejd.2011.1169","article-title":"Catabolism of pemphigus foliaceus autoantibodies by high-dose IVIg therapy","volume":"21","author":"Aoyama","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2008.05.026","article-title":"Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients","volume":"201\u2013202","author":"Baggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0015","doi-asserted-by":"crossref","first-page":"419520","DOI":"10.1155\/2010\/419520","article-title":"Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis","volume":"2010","author":"Blaha","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009167","article-title":"The role of MuSK in synapse formation and neuromuscular disease","volume":"5","author":"Burden","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/HYPERTENSIONAHA.109.148049","article-title":"Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice","volume":"55","author":"Cole","year":"2010","journal-title":"Hypertension."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0040","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0070","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0075","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"8","author":"Koneczny","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0955-3886(98)00022-8","article-title":"Plasmapheresis in myasthenia gravis. A survey","volume":"19","author":"Kuks","year":"1998","journal-title":"Transfus. Sci."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.11.001","article-title":"Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies","volume":"267","author":"Lagoumintzis","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06788.x","article-title":"Antigen-specific apheresis of autoantibodies in myasthenia gravis","volume":"1275","author":"Lazaridis","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2014.12.001","article-title":"Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains","volume":"278","author":"Lazaridis","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2016.12.011","article-title":"Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains","volume":"303","author":"Lazaridis","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0115","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jneuroim.2017.09.001","article-title":"Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis","volume":"312","author":"Lazaridis","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","article-title":"Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors\u2014recommendations for methods and experimental designs","volume":"270","author":"Losen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/jaut.1993.1057","article-title":"Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg","volume":"6","author":"Masson","year":"1993","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"5","author":"Otsuka","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00415-011-6194-7","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0155","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Res."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712590802588831","article-title":"A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis","volume":"9","author":"Ponseti","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mus.20515","article-title":"Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody","volume":"34","author":"Punga","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0175","first-page":"164","article-title":"Removal kinetics of therapeutic apheresis","volume":"5","author":"Reverberi","year":"2007","journal-title":"Blood Transfus."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneurol.2011.2200","article-title":"Acute severe animal model of anti-muscle-specific kinase myasthenia: combined postsynaptic and presynaptic changes","volume":"69","author":"Richman","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0185","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0190","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1510\/icvts.2007.170894","article-title":"Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study","volume":"7","author":"Sarkar","year":"2008","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2014.09.013","article-title":"Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy","volume":"276","author":"Skriapa","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jca.20129","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the apheresis applications Committee of the American Society for apheresis","volume":"22","author":"Szczepiorkowski","year":"2007","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jneuroim.2011.09.007","article-title":"Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis","volume":"240\u2013241","author":"Trakas","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2019.577136_bb2251","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000330031","article-title":". Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients.","volume":"20","author":"Tuzun","year":"2011","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mus.880130604","article-title":"Single-fiber electromyography in experimental autoimmune myasthenia gravis","volume":"13","author":"Verschuuren","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2019.577136_bb0220","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1537-2995.1982.22182154218.x","article-title":"Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange","volume":"22","author":"Volkin","year":"1982","journal-title":"Transfusion."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0230","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jca.21377","article-title":"Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients","volume":"30","author":"Yamada","year":"2015","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2007.05.033","article-title":"MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis","volume":"263","author":"Yeh","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0240","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0245","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2008.06.002","article-title":"Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients\u2019 sera using Escherichia coli-expressed receptor domains","volume":"200","author":"Zisimopoulou","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577136_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J. Autoimmun."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819304473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819304473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:15:30Z","timestamp":1778670930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819304473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":51,"alternative-id":["S0165572819304473"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577136","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577136"}}